WELL Health Technologies Corp
F:W7V

Watchlist Manager
WELL Health Technologies Corp Logo
WELL Health Technologies Corp
F:W7V
Watchlist
Price: 2.693 EUR 7.55%
Market Cap: €667.9m

Wall St Price Targets

W7V Price Targets Summary
WELL Health Technologies Corp

Wall Street analysts forecast W7V stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for W7V is 5.215 EUR with a low forecast of 3.711 EUR and a high forecast of 6.172 EUR.

Lowest Forecast
Price Target
3.711 EUR
38% Upside
Average Forecast
Price Target
5.215 EUR
94% Upside
Highest Forecast
Price Target
6.172 EUR
129% Upside
WELL Health Technologies Corp Competitors:
Price Targets
TNDM
Tandem Diabetes Care Inc
111% Upside
VNET
Vianet Group PLC
235% Upside

Revenue
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 9%.

Operating Income
Forecast

N/A
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate for Operating Income over the next 3 years is 4%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is W7V's stock price target?
Price Target
5.215 EUR

According to Wall Street analysts, the average 1-year price target for W7V is 5.215 EUR with a low forecast of 3.711 EUR and a high forecast of 6.172 EUR.

What is the Revenue forecast for WELL Health Technologies Corp?
Projected CAGR
9%

The compound annual growth rate for Revenue over the next 3 years is 9%.

What is the Operating Income forecast for WELL Health Technologies Corp?
Projected CAGR
4%

The compound annual growth rate for Operating Income over the next 3 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett